Granted Patent
B2
US 12,534,713 · App. 18/325,714 · Granted Jan 27, 2026
Chimeric alkaline phosphatase-like proteins
Inventors:
Willem Raaben (Amersfoort, NL); Luigi Johannes Cornelius Jonk (Utrecht, NL); Erik Jan Van Den Berg (Vught, NL); Andrea Van Elsas (Oakland, CA); José Luis Millán (Valley Center, CA)
Assignee:
AM-PHARMA B.V.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention relates to improved alkaline phosphatases, pharmaceutical compositions comprising improved alkaline phosphatases and the use of improved alkaline phosphatases for preventing, treating or curing diseases.
Claims (14)
1 . A method for improving, reducing or removing symptoms in a subject suffering from hypophosphatasia comprising administering to the subject: a protein having phosphatase activity, wherein said protein comprises an amino acid sequence of at least 200 consecutive amino acids having at least 90% sequence identity with SEQ ID NO: 5, an amino acid sequence of at least 50 consecutive amino acids, having at least 90% sequence identity with SEQ ID NO: 6, and an amino acid sequence of at least 40 consecutive amino acids having at least 90% sequence identity with SEQ ID NO: 7, wherein the full length protein comprises an amino acid sequence having at least 90% sequence identity with the full length amino acid sequence of SEQ ID NO: 1, with the proviso that the amino acid at position 279 is leucine (L), the amino acid at position 328 is valine (V) and the amino acid at position 478 is leucine (L).
2 . The method according to claim 1 , wherein said hypophosphatasia is perinatal hypophosphatasia.
3 . The method according to claim 1 , wherein the hypophosphatasia is adult hypophosphatasia.
4 . The method according to claim 1 , wherein said hypophosphatasia is infantile hypophosphatasia.
5 . The method according to claim 1 , wherein said hypophosphatasia is childhood hypophosphatasia.
6 . The method according to claim 1 , wherein the protein is administered to the subject by intravenous or subcutaneous administration.
7 . A method for improving, reducing or removing symptoms in a subject suffering from hypophosphatasia, said method comprising administering to the subject: a composition comprising a protein having phosphatase activity, wherein said protein comprises an amino acid sequence of at least 200 consecutive amino acids having at least 90% sequence identity with SEQ ID NO: 5, an amino acid sequence of at least 50 consecutive amino acids, having at least 90% sequence identity with SEQ ID NO: 6, and an amino acid sequence of at least 40 consecutive amino acids having at least 90% sequence identity with SEQ ID NO: 7, wherein the full length protein comprises an amino acid sequence having at least 90% sequence identity with the full length amino acid sequence of SEQ ID NO: 1, with the proviso that the amino acid at position 279 is leucine (L), the amino acid at position 328 is valine (V) and the amino acid at position 478 is leucine (L).
8 . The method according to claim 7 , wherein said improving, reducing or removing symptoms in a subject suffering from hypophosphatasia results in prolonged survival, increased body weight, improved skeletal phenotype, attenuation of craniofacial defects, improvement of dento-alveolar-phenotype, reduction of plasma PPi levels, reduction of PLP plasma levels, and/or attenuation of pain.
9 . The method according to claim 7 , wherein said improving, reducing or removing symptoms in a subject suffering from hypophosphatasia results in reduction of PLP plasma levels.
10 . The method according to claim 7 , wherein said improving, reducing or removing symptoms in a subject suffering from hypophosphatasia results in reduction of plasma PPi levels.
11 . The method according to claim 7 , wherein said hypophosphatasia is perinatal hypophosphatasia.
12 . The method according to claim 7 , wherein said hypophosphatasia is infantile hypophosphatasia.
13 . The method according to claim 7 , wherein said hypophosphatasia is perinatal hypophosphatasia.
14 . The method according to claim 7 , wherein the hypophosphatasia is adult hypophosphatasia.
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Nov 12, 2025
From: RAABEN, WILLEM; JONK, LUIGI JOHANNES CORNELIUS; VAN DEN BERG, ERIK JAN; VAN ELSAS, ANDREA; MILLÁN, JOSÉ LUIS
To: AM-PHARMA B.V.
Reel/Frame 072875/0794 →
CHANGE OF ADDRESS
Recorded Nov 12, 2025
From: AM-PHARMA B.V.
To: AM-PHARMA B.V.
Reel/Frame 073278/0235 →
Priority Claims (2)
EP 14152526
· Jan 24, 2014
· regional
EP 14188158
· Oct 8, 2014
· regional
Continuity (4)
Continuation
15113696
References Cited (196)
US 5567724A
· Kelleher et al.
· 1996
[cited by applicant]
US 5723441A
· Higley et al.
· 1998
[cited by applicant]
US 6290952B1
· Poelstra et al.
· 2001
[cited by applicant]
US 6406899B1
· Hoelke et al.
· 2002
[cited by applicant]
US 7157260B2
· Mori et al.
· 2007
[cited by applicant]
US 7157261B2
· Mayall et al.
· 2007
[cited by applicant]
US 7786082B2
· Kiss
· 2010
[cited by applicant]
US 7856139B2
· Chen
· 2010
[cited by applicant]
US 7973015B2
· Van Ommen et al.
· 2011
[cited by applicant]
US 8460654B2
· Kiss
· 2013
[cited by applicant]
US 8557545B2
· Velders et al.
· 2013
[cited by applicant]
US 8574863B2
· Brands et al.
· 2013
[cited by applicant]
US 8586032B2
· Pickkers et al.
· 2013
[cited by applicant]
US 8735087B2
· Brands et al.
· 2014
[cited by applicant]
US 8784805B2
· Brands
· 2014
[cited by applicant]
US 9926544B2
· Raaben et al.
· 2018
[cited by applicant]
US 20040146907A1
· Smith
· 2004
[cited by applicant]
US 20060099616A1
· Van Ommen et al.
· 2006
[cited by applicant]
US 20070059300A1
· Kiss
· 2007
[cited by applicant]
US 20080209581A1
· Van Ommen et al.
· 2008
[cited by applicant]
US 20090069244A1
· Brouwer et al.
· 2009
[cited by applicant]
US 20090228998A1
· Van Ommen et al.
· 2009
[cited by applicant]
US 20100016313A1
· Millan et al.
· 2010
[cited by applicant]
US 20110142817A1
· Brands et al.
· 2011
[cited by applicant]
US 20110206654A1
· Hodin et al.
· 2011
[cited by applicant]
US 20140193388A1
· Velders et al.
· 2014
[cited by applicant]
US 20140219984A1
· Arend et al.
· 2014
[cited by applicant]
US 20160046913A1
· Velders et al.
· 2016
[cited by applicant]
US 20160250299A1
· Arend et al.
· 2016
[cited by applicant]
CN 1425766A
· 2003
[cited by applicant]
EP 0151320A2
· 1985
[cited by applicant]
EP 1132086A2
· 2001
[cited by applicant]
EP 1733734A2
· 2006
[cited by applicant]
EP 1952823A1
· 2008
[cited by applicant]
EP 1985697A1
· 2008
[cited by applicant]
EP 2662448B1
· 2016
[cited by applicant]
JP H04349881A
· 1992
[cited by applicant]
JP H06284885A
· 1994
[cited by applicant]
JP H0998780A
· 1997
[cited by applicant]
JP H09172962A
· 1997
[cited by applicant]
JP 2000350596A
· 2000
[cited by applicant]
JP 2003146888A
· 2003
[cited by applicant]
JP 2005065564A
· 2005
[cited by applicant]
RU 2006103770A
· 2007
[cited by applicant]
WO WO9318139A1
· 1993
[cited by applicant]
WO WO9505455A1
· 1995
[cited by applicant]
WO WO9505456A1
· 1995
[cited by applicant]
WO WO9639203A1
· 1996
[cited by applicant]
WO WO0037943A1
· 2000
[cited by applicant]
WO WO0206214A1
· 2002
[cited by applicant]
WO WO02056900A2
· 2002
[cited by applicant]
WO WO02057430A2
· 2002
[cited by applicant]
WO WO02098433A1
· 2002
[cited by applicant]
WO WO03015817A2
· 2003
[cited by applicant]
WO WO2004056987A1
· 2004
[cited by applicant]
WO WO2005074978A1
· 2005
[cited by applicant]
WO WO2006096527A2
· 2006
[cited by applicant]
WO WO2008094037A1
· 2008
[cited by applicant]
WO WO2008104199A1
· 2008
[cited by applicant]
WO WO2008133511A2
· 2008
[cited by applicant]
WO WO2010025267A2
· 2010
[cited by applicant]
WO WO2012169892A2
· 2012
[cited by applicant]
WO WO2015112015A1
· 2015
[cited by applicant]
WO WO2015112017A1
· 2015
[cited by applicant]
Prasad, Clinical manifestations of zinc deficiency, Ann. Rev. Nutr. 5, 1985, 341-63. (Year: 1985).
[cited by examiner]
Kurko et al., Genetics of rheumatoid arthritis, Clinic. Rev. Allerg. Immunol. 45, 2013, 170-170. (Year: 2013).
[cited by examiner]
De Medina et al., Induction of alkaline phosphatase in the inflamed intestine: a novel pharmacological target for inflammatory bowel disease, Biochem. Pharmacol. 68, 2004,: 2317-26. (Year: 2004).
[cited by examiner]
Narisawa et al, Novel Inhibitors of Alkaline Phosphatase Suppress Vascular Smooth Muscle Cell Calcification, J. Bone Min. Res. 22, 2007, 1700-10. (Year: 2007).
[cited by examiner]
Hofmann et al., Clinical aspects of hypophosphatasia, Clinic Rev. Bone Miner. Metab. 11, 2013, 60-70. (Year: 2013).
[cited by examiner]
Anderson, H.C., et al., “Impaired Calcification Around Matrix Vesicles of Growth Plate and Bone in Alkaline Phosphatase-deficient Mice,” The American Journal of Pathology 164(3):841-847, Elsevier, United States (2004).
[cited by applicant]
Bauerle, J.D et al., “Adenosine Generation and Signaling During Acute Kidney Injury,” Journal of the American Society of Nephrology 22(1):14-20, American Society of Nephrology, United States (2011).
[cited by applicant]
Berger, J., et al., “Cloning and Sequencing of Human Intestinal Alkaline Phosphatase cDNA,” Proceedings of the National Academy of Sciences USA 84:695-698, National Academy of Sciences, United States (1987).
[cited by applicant]
Bernstine, E.G., et al., “Alakaline Phosphatase Activity in Mouse Teratoma,” Proceedings of the National Academy of Sciences USA 70(12):3899-3903, National Academy of Sciences, United States (1973).
[cited by applicant]
Beumer, C., et al., “Calf Intestinal Alkaline Phosphatase, a Novel Therapeutic Drug for Lipopolysaccharide (LPS)-mediated Diseases, Attenuates LPS Toxicity in Mice and Piglets,” Journal of Pharmacology and Experimental …
[cited by applicant]
Bol-Schoenmakers, M., et al., “Intestinal Alkaline Phosphatase Contributes to the Reduction of Severe Intestinal Epithelial Damage,” European Journal of Pharmacology 633(1-3):71-77, Elsevier Science, Netherlands (2010).
[cited by applicant]
Bossi, M., et al., “Modifications in a Flexible Surface Loop Modulate the Isozyme-specific Properties of Mammalian Alkaline Phosphatases,” Journal of Biological Chemistry 34:25409-25416, American Society for Biochemistr…
[cited by applicant]
Boulain, J., et al., Patent Abstracts of Japan, English language Abstract of Japanese Patent Publication No. 09-098780, “Modified Baterium Alkaline Phosphatase and Its Use,” Japanese Patent Office, Patent & Utility Mode…
[cited by applicant]
Bouxsein, M.L., et al., “Guidelines for Assessment of Bone Microstructure in Rodents Using Micro-computed Tomography,” Journal of Bone and Mineral Research 25(7):1468-1486, American Society for Bone and Mineral Research…
[cited by applicant]
Brennan, C.A., et al., “A Molecular Sensor System Based On Genetically Engineered Alkaline Phosphatase,” Proceedings of the National Academy of Sciences of the United States of America 92: 5783-5787, National Academy of…
[cited by applicant]
Chen, K.T., et al., “Identification of Specific Targets for the Gut Mucosal Defense Factor Intestinal Alkaline Phosphatase,” American Journal of Physiology. Gastrointestinal and Liver Physiology 299(2):G467-G475, Americ…
[cited by applicant]
Di Sole, F., “Adenosine and Renal Tubular Function,” Current Opinion in Nephrology and Hypertension 17(4):399-407, Lippincott Williams & Wilkins, England (2008).
[cited by applicant]
Eltzschig, H.K., et al., “Purinergic Signaling During Inflammation,” The New England Journal of Medicine 367(24):2322-2333, Massachusetts Medical Society, United States (2012).
[cited by applicant]
Engle, M.J., et al., “Two Rat Intestinal Alkaline Phosphatase Isoforms with Different Carboxyl-terminal Peptides are Both Membrane-bound by a Glycan Phosphatidylinositol Linkage,” Journal of Biological Chemistry 20:1193…
[cited by applicant]
English language Abstract and machine translation of Japanese Patent Publication No. 09-172962 A, Japanese Patent Office, Jul. 8, 1997.
[cited by applicant]
English Language Abstract for CN1425766, Published Jun. 25, 2003.
[cited by applicant]
Eriksson H.J., et al., “Investigations into the Stabilization of Drugs by Sugar Glasses: Delivery of an Insulin-stabilised Alkaline Phosphatase in the Intestinal Lumen Via the Oral Route” International Journal of Pharma…
[cited by applicant]
Fedde, K.N., et al., “Alkaline Phosphatase Knock-out Mice Recapitulate the Metabolic and Skeletal Defects of Infantile Hypophosphatasia,” Journal of Bone and Mineral Research 14(12):2015-2026, American Society for Bone …
[cited by applicant]
Foster, B.L., et al., “Central Role of Pyrophosphate in Acellular Cementum Formation,” PLoS One 7(6):e38393, Public Library of Science, United States (2012).
[cited by applicant]
Foster, B.L., et al., “Rare Bone Diseases and Their Dental, Oral, and Craniofacial Manifestations,” Journal of Dental Research 93(7suppl):7S-19S, Sage, United States (2014).
[cited by applicant]
Foster, B.L., et al., “The Rachitic Tooth,” Endocrine Reviews 35(1):1-34, Endocrine Society, United States (2014).
[cited by applicant]
Foster, B.L., et al., “Tooth Root Dentin Mineralization Defects in a Mouse Model of Hypophosphatasia,” Journal of Bone and Mineral Research 28(2):271-282, American Society for Bone and Mineral Research, United States (2…
[cited by applicant]
Gayle, R.B., III, et al., “Identification of Regions in Interleukin-lα Important for Activity,” The Journal of Biological Chemistry 268(29):22105-22111, The American Society for Biochemistry and Molecular Biology, Inc.,…
[cited by applicant]
Greenwood, F.C., et al., “The Preparation of I-131-labelled Human Growth Hormone of High Specific Radioactivity,” The Biochemical Journal 89:114-123, Portland Press on behalf of the Biochemical Society, England (1963).
[cited by applicant]
Harms, G., et al., “Immunopathology of Alkaline Phosphatase-induced Granulomatous Hepatitis in Rats,” Virchows Archiv. B, Cell Pathology Including Molecular Pathology 62(1):35-43, Springer-Verlag, Germany (1992).
[cited by applicant]
Heemskerk, S., et al., “Alkaline Phosphatase Treatment Improves Renal Function in Severe Sepsis or Septic Shock Patients,” Critical Care Medicine 37(2):417-423, Lippincott Williams & Wilkins, United States (2009).
[cited by applicant]
Henthorn, P., et al., “Nucleotide and Amino Acid Sequences of Human Intestinal Alkaline Phosphatase: Close Homology to Placental Alkaline Phosphatase,” Proceedings of the National Academy of Sciences USA 84(12):4088, Na…
[cited by applicant]
Henthorn, P., et al., “Nucleotide and Amino Acid Sequences of Human Intestinal Alkaline Phosphatase: Close Homology to Placental Alkaline Phosphatase,” Proceedings of the National Academy of Sciences USA 84:1234-1238, N…
[cited by applicant]
Henthorn, P.S., et al., “Sequence and Characterization of the Human Intestinal Alkaline Phosphatase Gene,” The Journal of Biological Chemistry 263:12011-12019, American Society for Biochemistry and Molecular Biology, Un…
[cited by applicant]
Hessle, L., et al., “Tissue-nonspecific Alkaline Phosphatase and Plasma Cell Membrane Glycoprotein-1 Are Central Antagonistic Regulators of Bone Mineralization,” Proceedings of the National Academy of Sciences of the US…
[cited by applicant]
Hobson, C.E., et al., “Acute Kidney Injury is Associated with Increased Long-term Mortality after Cardiothoracic Surgery,” Circulation 119(18):2444-2453, Lippincott Williams & Wilkins, United States (2009).
[cited by applicant]
Huesa, C., et al., “PHOSPHO1 is Essential for Mechanically Competent Mineralization and the Avoidance of Spontaneous Fractures,” Bone 48(5):1066-1074, Elsevier Science, United States (2011).
[cited by applicant]
International Search Report for International Application No. PCT/NL2015/050048, European Patent Office, Netherlands, mailed on May 11, 2015, 4 pages.
[cited by applicant]
Jacob, S., et al., “Pharmacotherapy of Atrial Fibrillation: A Pathophysiological Perspective and Review,” American Journal of Therapeutics 18(3):241-260, Lippincott Williams & Wilkins, United States (2011).
[cited by applicant]
Kats, S., et al., “Anti-inflammatory Effects of Alkaline Phosphatase in Coronary Artery Bypass Surgery with Cardiopulmonary Bypass,” Recent Patents on Inflammation & Allergy Drug Discovery 3(3):214-220, Bentham Science …
[cited by applicant]
Kiffer-Moreira, T., et al., “Catalytic Signature of a Heat-stable, Chimeric Human Alkaline Phosphatase With Therapeutic Potential,” PLoS One 9(2):e89374, Public Library of Science, United States (2014).
[cited by applicant]
Kodama, H., et al., “Expression of a Heterodimeric (placental-intestinal) Hybrid Alkaline Phosphatase in KB Cells” Biochimica et Biophysica Acta 1218:163-172, Elsevier Pub. Co., Netherlands (1994).
[cited by applicant]
Koyama, I., et al., “Alkaline Phosphatases Reduce Toxicity of Lipopolysaccharides in Vivo and in Vitro through Dephosphorylation,” Clinical Biochemistry 35(6):455-461, Elsevier Science, United States (2002).
[cited by applicant]
Kozlenkov, A., et al., “Function Assignment to Conserved Residues in Mammalian Alkaline Phosphatases,” The Journal of Biological Chemistry 277(25):22992-22999, American Society for Biochemistry and Molecular Biology, Un…
[cited by applicant]
Kozlenkov, A., et al., “Residues Determining the Binding Specificity of Uncompetitive Inhibitors to Tissue-nonspecific Alkaline Phosphatase,” Journal of Bone and Mineral Research 19(11):1862-1872, American Society for B…
[cited by applicant]
Lameire, N.H., et al., “Acute Kidney Injury: an Increasing Global Concern,” Lancet 382(9887):170-179, Elsevier, England (2013).
[cited by applicant]
Le Du, M.H, and Millian, J.L., “Structural Evidence of Functional Divergence in Human Alkaline Phosphatases.” Journal of Biological Chemistry 277(51):49808-49814, American Society for Biochemistry and Molecular Biology,…
[cited by applicant]
Lee, J.Y., et al., “Erdosteine in Renal Ischemia-reperfusion Injury: an Experimental Study in Pigs,” The Journal of Veterinary Medical Science 72(1): 127-130, Japanese Society Of Veterinary Science, Japan (2010).
[cited by applicant]
Leibovitch, I., et al., “Increased Serum Alkaline Phosphatase Activity: A Possible Indicator of Renal Damage,” Journal of Clinical Laboratory Analysis 5(6):406-409, Wiley-Liss, Inc., United States (1991).
[cited by applicant]
Lindner, N.M., et al., “Design and Applications of Biomimetic Anthraquinone Dyes. Purification of Calf Intestinal Alkaline Phosphatase With Immobilised Terminal Ring Analogues of C.I. Reactive Blue 2,” Journal of Chroma…
[cited by applicant]
Liu, J., et al., “Tissue-nonspecific Alkaline Phosphatase Deficiency Causes Abnormal Craniofacial Bone Development in the Alpl(−/−) Mouse Model of Infantile Hypophosphatasia,” Bone 67:81-94, Elsevier Science, United Sta…
[cited by applicant]
Lukas, M., et al., “Exogenous Alkaline Phosphatase for the Treatment of Patients With Moderate to Severe Ulcerative Colitis,” Inflammatory Bowel Diseases 16(7):1180-1186, Lippincott Williams & Wilkins, United States (20…
[cited by applicant]
Mandecki, W., et al., Patent Abstracts of Japan, English language Abstract of Japanese Patent Publication No. 04-349881, “Synthesized Alkaline Phosphatase Enzyme Having Improved Specific Activity,” Japanese Patent Offic…
[cited by applicant]
Martinez-Moya, P., et al., “Exogenous Alkaline Phosphatase Treatment Complements Endogenous Enzyme Protection in Colonic Inflammation and Reduces Bacterial Translocation in Rats,” Pharmacological Research 66(2):144-153,…
[cited by applicant]
Mayo Clinic Staff, “Diseases and Conditions Acute kidney failure,” accessed at http://www.mayoclinic.org/diseases-conditions/kidney-failure/basics/prevention/con-20024029?p=1 accessed on Jul. 24, 2015, 7 pages (2015).
[cited by applicant]
Mckee, M.D., et al., “Enzyme Replacement Therapy Prevents Dental Defects in a Model of Hypophosphatasia,” Journal of Dental Research 90(4):470-476, American Dental Assn, United States (2011).
[cited by applicant]
Meganck, J.A., et al., “Beam Hardening Artifacts in Micro-computed Tomography Scanning Can Be Reduced by X-ray Beam Filtration and the Resulting Images Can Be Used to Accurately Measure BMD,” Bone 45(6):1104-1116, Elsev…
[cited by applicant]
Millan, J.L., et al., “Enzyme Replacement Therapy for Murine Hypophosphatasia,” Journal of Bone and Mineral Research 23(6):777-787, American Society for Bone and Mineral Research, United States (2008).
[cited by applicant]
Millan, Jose Luis, “Alkaline Phosphatases: Structure, Substrate Specificity and Functional Relatedness to Other Members of a Large Superfamily of Enzymes,” Purinergic Signaling 2:335-341, Springer, Netherlands (2006).
[cited by applicant]
Mornet, E., et al., “Structural Evidence for a Functional Role of Human Tissue Nonspecific Alkaline Phosphatase in Bone Mineralization,” Journal of biological chemistry 26:31171-31178, American Society for Biochemistry …
[cited by applicant]
Naber, T.H., et al., “Serum Alkaline Phosphatase Activity During Zinc Deficiency and Long-term Inflammatory Stress,” Clinica Chimica Acta 249:109-127, Elsevier, Netherlands (1996).
[cited by applicant]
Narisawa, S., et al., “A Novel Phosphatase Upregulated in Akp3 Knockout Mice,” American Journal of Physiology Gastrointestinal and liver physiology 293(5):G1068-G1077, American Physiological Society, United States (2007…
[cited by applicant]
Narisawa, S., et al., “Abnormal Vitamin B6 Metabolism in Alkaline Phosphatase Knock-out Mice Causes Multiple Abnormalities, but Not the Impaired Bone Mineralization,” The Journal of Pathology 193(1):125-133, John Wiley …
[cited by applicant]
Narisawa, S., et al., “Inactivation of Two Mouse Alkaline Phosphatase Genes and Establishment of a Model of Infantile Hypophosphatasia,” Developmental Dynamics 208(3):432-446, Wiley, United States (1997).
[cited by applicant]
NCBI Acct #NP_001622.2 versus Bossi et al., USPTO in house alignment Feb. 22, 2012.
[cited by applicant]
Nugent, S.G., et al., “Review: Intestinal Luminal pH in Inflammatory Bowel Disease: Possible Determinants and Implications for Therapy with Aminosalicylates and Other Drugs,” Gut 48:571-577, British Medical Association,…
[cited by applicant]
Okamoto, M., et al., Patent Abstracts of Japan, English language Abstract of Japanese Patent Publication No. 2000-350596, “Selective Assay of Secreted Alkaline Phosphatase Activity,” Japanese Patent Office, Patent & Uti…
[cited by applicant]
Peters, E., et al., “Alkaline Phosphatase: a Possible Treatment for Sepsis-associated Acute Kidney Injury in Critically ill Patients,” American Journal of Kidney Diseases 63(6):1038-1048, W.B. Saunders, United States (2…
[cited by applicant]
Peters, E., et al., “Alkaline Phosphatase as a Treatment of Sepsis-associated Acute Kidney Injury,” The Journal of Pharmacology and Experimental Therapeutics 344(1):2-7, American Society for Pharmacology and Experimenta…
[cited by applicant]
Pickkers, P., et al., “Alkaline Phosphatase for Treatment of Sepsis-induced Acute Kidney Injury: a Prospective Randomized Double-blind Placebo-controlled Trial,” Critical Care 16(1):R14, BioMed Central Ltd, England (201…
[cited by applicant]
Poelstra, K., et al., “Dephosphorylation of Endotoxin by Alkaline Phosphatase in Vivo,” American Journal of Pathology 151(4):1163-1169, Elsevier, United States (1997).
[cited by applicant]
Ramasamy, S., et al., “Intestinal Alkaline Phosphatase Has Beneficial Effects in Mouse Models of Chronic Colitis,” Inflammatory Bowel Diseases 17(2):532-542, Lippincott Williams & Wilkins, United States (2011).
[cited by applicant]
Reinecke, H., et al., “Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease,” Journal of the American Society of Nephrology 20(4):705-711, American Society of Nephrology, United States (2009).
[cited by applicant]
Riggle, K.M., et al., “Intestinal Alkaline Phosphatase Prevents the Systemic Inflammatory Response Associated With Necrotizing Enterocolitis,” The Journal of Surgical Research 180(1):21-26, Academic Press, United States…
[cited by applicant]
Sanchez De Medina F., et al., “Induction of Alkaline Phosphatase in the Inflamed Intestine: A Novel Pharmacological Target for Inflammatory Bowel Disease,” Biochemical Pharmacology, 68:2317-2326, Elsevier Science, Engla…
[cited by applicant]
Schock-Kusch, D., et al., “Transcutaneous Assessment of Renal Function in Conscious Rats With a Device for Measuring Fitc-sinistrin Disappearance Curves, ” Kidney International 79(11):1254-1258, Elsevier, United States …
[cited by applicant]
Schock-Kusch, D., et al., “Transcutaneous Measurement of Glomerular Filtration Rate Using FITC-sinistrin in Rats,” Nephrology, Dialysis, Transplantation 24(10):2997-3001, Oxford University Press, England (2009).
[cited by applicant]
Shahani, K.M., et al., “Enzymes in Bovine Milk: A Review,” Journal of Dairy Science 56(5):531-543, American Dairy Science Association, United States (1973).
[cited by applicant]
Shulka, et al., “Host Cell Protein Clearance During Protein a Chromatography: Development of an Improved Column Wash Step,” Biotechnology Progress 24(5):1115-1121, American Institute of Chemical Engineers (2008).
[cited by applicant]
Su, F., et al., “Beneficial Effects of Alkaline Phosphatase in Septic Shock,” Critical Care Medicine 34(8):2182-2187, Kolen, United States (2006).
[cited by applicant]
Szuster-Ciesielska, et al., “The Inhibitory Effect of Zinc on Cadmium-induced Cell Apoptosis and Reactive Oxygen Species (ROS) Production in Cell Cultures,” Toxicology 145(2-3):159-171, Elsevier, Ireland (2000).
[cited by applicant]
The New York Times, “Chronic Kidney Disease Overview,” accessed at http://nytimes.com/health/guides/disease/chronic-renal-failure/overview.html?print=1, accessed on Jul. 24, 2015, 3 pages (2015).
[cited by applicant]
Tuin, A., et al., “Role of Alkaline Phosphatase in Colitis in Man and Rats,” Gut 58(3):379-387, British Medical Assn, England (2009).
[cited by applicant]
Tuin, et al., “Oral Administration of Alkaline Phosphatase Ameliorates Colitis.” Gastroenterology 132:A231, Abstract #51611 (2007).
[cited by applicant]
Udenfriend, S., et al., “Prediction of Omega Site in Nascent Precursor of Glycosylphophatidylinositol Protein,” Methods Enzymology, 250:571-582, Academic Press, United States (1995).
[cited by applicant]
Ueda, Hiroshi, Patent Abstract of Japan, English language Abstract of Japanese Patent Publication No. 2005-065564, “Sensor Protein,” Japanese Patent Office, Patent & Utility Model Gazette DB (2005).
[cited by applicant]
Umoh, J.U., et al., “In Vivo Micro-CT Analysis of Bone Remodeling in a Rat Calvarial Defect Model,” Physics in Medicine and Biology 54(7):2147-2161, IOP Publishing, England (2009).
[cited by applicant]
Unknown Author, “Chronic Kidney Disease—information Prescription,” accessed at http://nhs.uk.Pages/Preview.aspx?site=Kidney-disease-chronic&print=63573354618, accessed on Jul. 24, 2015, 3 pages (2013).
[cited by applicant]
Van Veen, S.Q., et al., “Alkaline Phosphatase Reduces Hepatic and Pulmonary Injury in Liver Ischaemia—reperfusion Combined with Partial Resection,” The British Journal of Surgery 93: 448-456, Wiley, England (2006).
[cited by applicant]
Van Veen, S.Q., et al., “Bovine Intestinal Phosphatase Attenuates the Inflammatory Response in Secondary Peritonitis in Mice,” Infection and Immunity 73: 4309-4315, American Society For Microbiology, United States (2005…
[cited by applicant]
Verweij, W.R., et al., “Protection Against an
[cited by applicant]
Wang, E., et al., “Crystal Structure of Alkaline Phosphatase from the Antarctic Bacterium TAB5,” Journal of Molecular Biology 366:1318-1331, Elsevier Ltd., England (2007).
[cited by applicant]
Whisstock, et al., “Prediction of Protein Function From Protein Sequence and Structure,” Quarterly Reviews of Biophysics 3:307-340 (2003).
[cited by applicant]
Whyte, M.P., et al., “Enzyme Replacement Therapy for Infantile Hypophosphatasia Attempted by Intravenous Infusions of Alkaline Phosphatase-rich Paget Plasma: Results in Three Additional Patients,” The Journal of Pediatr…
[cited by applicant]
Whyte, M.P., et al., “Enzyme-replacement Therapy in Life-threatening Hypophosphatasia,” The New England Journal of piMedicine 366(10):904-913, Massachusetts Medical Society, United States (2012).
[cited by applicant]
Whyte, M.P., et al., “Infantile Hypophosphatasia: Enzyme Replacement Therapy by Intravenous Infusion of Alkaline Phosphatase-rich Plasma From Patients With Paget Bone Disease,” The Journal of Pediatrics 101(3):379-386, …
[cited by applicant]
Wilmer, M.J., et al., “Novel Conditionally Immortalized Human Proximal Tubule Cell Line Expressing Functional Influx and Efflux Transporters,” Cell and Tissue Research 339(2):449-457, Springer-Verlag, Germany (2010).
[cited by applicant]
Wray, L., and Harris H., “Demonstration Using Monoclonal Antibodies of Inter-Locus Heteromeric Isozymes of Human Alkaline Phosphatase” Journal of Immunological Methods 55:13-18, Elsevier, Netherlands (1982).
[cited by applicant]
Wuhl, E., et al., “Antihypertensive and Antiproteinuric Efficacy of Ramipril in Children with Chronic Renal Failure,” Kidney International 66:768-776, International Society of Nephrology, United States (2004).
[cited by applicant]
Xu, et al., “Directed Evolution of
[cited by applicant]
Yadav, M.C., et al., “Ablation of Osteopontin Improves the Skeletal Phenotype of Phospho1(−/−) Mice,” Journal of Bone and Mineral Research 29(11):2369-2381, American Society for Bone and Mineral Research, United States …
[cited by applicant]
Yadav, M.C., et al., “Dose Response of Bone-targeted Enzyme Replacement for Murine Hypophosphatasia,” Bone 49(2):250-256, Elsevier Science, United States (2011).
[cited by applicant]
Yadav, M.C., et al., “Enzyme Replacement Prevents Enamel Defects in Hypophosphatasia Mice,” Journal of Bone and Mineral Research 27(8):1722-1734, American Society for Bone and Mineral Research, United States (2012).
[cited by applicant]
Zarbock, A., and Milles, K., “Novel Therapy for Renal Protection,” Current Opinion in Anesthesiology 28(4):431-438, Lippincott Williams & Wilkins, United States (2015).
[cited by applicant]
Office Action mailed Mar. 30, 2017, in U.S. Appl. No. 15/113,696, Raaben, W., et al., filed Jul. 22, 2016, 10 pages.
[cited by applicant]
Office Action mailed Sep. 20, 2019, in U.S. Appl. No. 15/891,208, Raaben, W., et al., filed Feb. 7, 2018, 12 pages.
[cited by applicant]
Daan De Boer, J., et al., “Lipopolysaccharide Inhibits Th2 Lung Inflammation Induced by House Dust Mite Allergens in Mice,” American Journal of Respiratory Cell and Molecular Biology 48(3):382-389, American Thoracic Soc…
[cited by applicant]
Wang, J., et al., “Lipopolysaccharide promotes lipid accumulation in human adventitial fibroblasts via TLR4-NF-κB pathway,” Lipids in Health and Disease 11:139, BioMed Central, United Kingdom (2012).
[cited by applicant]
Zappa, S., et al., “Characterization of a Highly Thermostable Alkaline Phosphatase from the Euryarchaeon Pyrococcus abyssi,” Applied and Environmental Microbiology 67(10):4504-4511, American Society for Microbiology, Un…
[cited by applicant]
Butler, J., et al., “Relationship between heart failure treatment and development of worsening renal function among hospitalized patients,” American Heart Journal 147(2):331-338, Elsevier Inc. (2004).
[cited by applicant]
Damman, K., et al., “Worsening Renal Function and Prognosis in Heart Failure: Systematic Review and Meta-Analysis,” Journal of Cardiac Failure 13(8):599-609 (2007).
[cited by applicant]
Prasad, A., “Clinical manifestations of zinc deficiency,” Annu Rev Nutr. 5:341-363, Annual Reviews, United States. (Jul. 1985).
[cited by applicant]
Kurko, J., et al., “Genetics of Rheumatoid Arthritis—A Comprehensive Review,” Clin Rev Allergy Immunol. 45(2):170-170, Springer Nature, Germany (Oct. 2013).
[cited by applicant]
Nayerossadat, N., et al., “Viral and nonviral delivery systems for gene delivery,” Adv Biomed Res. 1:27, Wolters Kluwer, Netherlands (Jul. 2012).
[cited by applicant]
Narisawa, S., et al., “Novel Inhibitors of Alkaline Phosphatase Suppress Vascular Smooth Muscle Cell Calcification,” J Bone Miner Res. 22(11):1700-1710, American Society for Bone and Mineral Research, United States (Nov…
[cited by applicant]
Whyte, M., “Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges,” J Bone Miner Res. 32(4):667-675, American Society for Bone and Mineral Research, United States (Apr. 2017).
[cited by applicant]